Data Analysis
Analyze screens to study the binding efficacy and strength of effect, developing leads and narrowing the funnel of potential hits. Statistical analyses for secondary screening are more complex than those for primary screening. With the Genedata Biopharma Platform, automate and streamline the capture, analysis and management of screening data acquired at any throughput. This includes complex methods, such as high-content screening and high-throughput mass spectrometry. Maintain records of secondary screening and pull data from instruments into IDBS Polar Biopharma Lifecycle Management software.